Immunohistochemical staining for EphA2, using an antibody validated in human tumor samples and in EphA2‐deficient mice,36 was performed in a set samples from de‐identified patients with human breast cancer bone metastases (generously provided by Dr Conor Lynch). This evidence concerns the gene EPHA2 and neoplasm.